Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1846-1849

  Chern, Herng Der ^a   Becich, Michael J ^a   Persad, Raj A ^a   Romkes, Marjorie ^a   Smith, Patrick ^a   Collins, Chris ^a   Li, Yi Hwei ^a   Branch, Robert A ^a  

^a NONE

Author keywords

bladder neoplasms; genes; p53; retinoblastoma

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BLADDER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER; SUPERFICIAL CANCER;

EID: 0029903982     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65550-2     Document Type: Article

References (30)

1. Fitzpatrick, J. M., West, A. B., Butler, M. R., Lane, V. and O'Flynn, J. D.: Superficial bladder tumors (stage pTa, grade 1 and 2): the importance of recurrence pattern following initial resection. J. Urol., 135: 920, 1986.
2. Richie, J. P., Shipley, W. U. and Yagoda, A.: Cancer of the bladder. In: Cancer: Principles and Practice of Oncology. Edited by V. T. DeVita, S. Hellman and S. A. Rosenberg. Philadelphia: J. B. Lippincott, vol. 1. pp. 1008-1022, 1989.
3. Sidransky, D., Frost, P., Von Eschenbach, A., Oyasu, R., Preisinger, A. C. and Vogelstein, B.: Clonal origin of bladder cancer. New Engl. J. Med., 326: 737, 1992.
4. Habuchi, T., Takahashi, R., Yamada, H., Kakehi, Y., Sugiyama, T. and Yoshida, O.: Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet, 342: 1087, 1993.
5. Miyao, N., Tsai, Y. C., Lerner, S. P., Olumi, A. F., Spruck, C. H., González-Zulueta, M., Nichols, P. W., Skinner, D. G. and Jones, P. A.: Role of chromosome 9 in human bladder cancer. Cancer Res., 53: 4066, 1993.
6. Spruck, C. H., Ohneseit, P. F., González-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S., Cote, R., Dubeau, L., Nichols, P. W., Hermann, G. G., Steven, K., Horn, T., Skinner, D. G. and Jones, P. A.: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784, 1994.
7. Cordon-Cardo, C., Wartinger, D., Petrylak, D., Dalbagni, G., Fair, W. R., Fuks, Z. and Reuter, V. E.: Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl. Cancer Inst., 84: 1251, 1992.
8. Logothetis, C. J., Xu, H.-J., Ro, J. Y., Hu, S.-X., Sahin, A., Ordonez, N. and Benedict, W. F.: Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst., 84: 1256, 1992.
9. Linzer, D. I. and Levine, A. J.: Characterization of a 54 kd cellular SV40 tumor antigen present in SV-40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17: 43, 1979.
10. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W., Plunkett, B. S., Vogelstein, B. and Fornace, A. J.: A mammalian cell cycle checkpoint pathway utilizing P53 and GADD45 is defective in ataxia telangiectasia. Cell, 71: 587, 1992.
11. Vogelstein, B. and Kinzler, K. W.: P53 function and disfunction. Cell, 70: 523, 1992.
12. Lane, D. P.: P53, guardian of the genome. Nature, 358: 15, 1992.
13. Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M. and Levine, A. J.: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8: 531, 1988.
14. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z.-F., Sheinfeld, J., Fair, W. R., Herr, H. W. and Reuter, V. E.: Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J. Natl. Cancer Inst., 85: 53, 1993.
15. Iggo, R., Gatter, K., Bartek, J., Lane, D. and Harris, A. L.: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet, 335: 675, 1990.
16. Wright, C., Mellon, K., Johnston, P., Lane, D. D., Harris, A. L., Horne, C. H. and Neal, D. E.: Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br. J. Cancer, 63: 967, 1991.
17. Maestro, R., Dolcetti, R., Gasparotto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E. and Boiocchi, M.: High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene, 7: 1159, 1992.
18. Dalbagni, G., Presti, J. C., Reuter, V. E., Zhang, Z. F., Sarkis, A. S., Fair, W. R. and Cordon-Cardo, C.: Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn. Mol. Pathol., 2: 4, 1993.
19. Cordon-Cardo, C., Dalbagni, G., Saez, G. T., Oliva, M. R., Zhang, Z.-F., Rosai, J., Reuter, V. E. and Pellicer, A.: p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int. J. Cancer, 56: 347, 1994.
20. Lee, W.-H., Shew, J.-Y., Hong, F. D., Sery, T. W., Donoso, L. A., Young, L. J., Bookstein, R. and Lee, E. Y.: The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature, 329: 642, 1987.
21. Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A. and Harlow, E.: Association between an oncogene and anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature, 334: 124, 1988.
22. Goodrich, D. W., Wang, N. P., Qian, Y.-W., Lee, E. Y. and Lee, W. H.: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell, 67: 293, 1991.
23. Lees, J. A., Buchkovich, K. J., Marshak, D. R., Anderson, C. W. and Harlow, E.: The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. E.M.B.O.J., 10: 4279, 1991.
24. Mostofi, F. K.: International histologic classification of tumors. A report by the Executive Committee of the International Council of Societies of Pathology. Cancer, 33: 1484, 1974.
25. Griner, P. F., Mayewski, R. J., Mushlin, A. I. and Greenland, P.: Selection and interpretation of diagnostic tests and procedures: principles and applications. Ann. Intern. Med., 84: 453, 1981.
26. Yao, A. and Rubin, H.: A critical test of the role of population density in producing transformation. Proc. Natl. Acad. Sci. U.S.A., 91: 7712, 1994.
27. Sarkis, A., Dalbagni, G., Cordon-Cardo, C., Melamed, J., Zhang, Z.-F., Sheinfeld, J., Fair, W. R., Herr, H. W. and Reuter, V. E.: Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol., 152: 388, 1994.
28. Lipponen, P. K.: Over-expression of p53 nuclear oncoprotein in transitional cell bladder cancer and its prognostic value. Int. J. Cancer, 53: 365, 1993.
29. Lamm, D. L.: Optimal BCG treatment of superficial bladder cancer as defined by American trials. Eur. Urol., suppl. 2, 21: 126, 1992.
30. DeHaven, J. I., Traynellis, C., Riggs, D. R., Ting, E. and Lamm, D. L.: Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guerin toxicity. J. Urol., 147: 738, 1992.